COVID-19 vaccines shipped by COVAX arrive to the Republic of Moldova
Moldova became the first country in the European region to receive the COVID-19 vaccine from the COVAX initiative.
On March 4, Moldova received 14 400 doses of the anti-COVID-19 vaccine, shipped via the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO. Moldova is the first country in Europe to receive vaccines from the COVAX facility.
The arrival marked a historic step towards the goal to ensure equitable distribution of anti-COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history. The delivery is part of a first wave of arrivals in Moldova that will continue in the coming days and weeks.
The COVAX Facility is expected to deliver 24,570 doses of BioNTech- Pfizer COVID-19 vaccine and up to 264,000 indicative doses of AstraZeneca / SKBio COVID-19 vaccine to the Republic of Moldova in 2021.
Team Europe, bringing together EU and its Member States, is one of the lead contributors to COVAX with over €2.2 billion, including another €900 million recently pledged by Germany.
The EU's response to the coronavirus pandemic follows a ‘Team Europe' approach, aimed at saving lives by providing quick and targeted support to our partners to face this pandemic. It combines resources from the EU, its Member States and financial institutions, in particular the European Investment Bank and the European Bank for Reconstruction and Development.
